This pipeline uses various statistical tests to identify genes whose promoter methylation levels correlated to selected clinical features.
Testing the association between 19042 genes and 4 clinical features across 194 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.
-
138 genes correlated to 'AGE'.
-
TMEM20 , ANGPTL5 , KIAA1377 , JAKMIP1 , AASS , ...
-
15 genes correlated to 'GENDER'.
-
DKFZP434L187 , AP2B1 , FAM35A , GLUD1 , CROCC , ...
-
4 genes correlated to 'RACE'.
-
GRAP , FAM66D__2 , LOC392196 , CPNE7
-
No genes correlated to 'Time to Death'
Complete statistical result table is provided in Supplement Table 1
Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.
| Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
|---|---|---|---|---|---|---|
| Time to Death | Cox regression test | N=0 | ||||
| AGE | Spearman correlation test | N=138 | older | N=36 | younger | N=102 |
| GENDER | Wilcoxon test | N=15 | male | N=15 | female | N=0 |
| RACE | Kruskal-Wallis test | N=4 |
Table S1. Basic characteristics of clinical feature: 'Time to Death'
| Time to Death | Duration (Months) | 0.9-94.1 (median=12) |
| censored | N = 63 | |
| death | N = 106 | |
| Significant markers | N = 0 |
Table S2. Basic characteristics of clinical feature: 'AGE'
| AGE | Mean (SD) | 55.11 (16) |
| Significant markers | N = 138 | |
| pos. correlated | 36 | |
| neg. correlated | 102 |
Table S3. Get Full Table List of top 10 genes significantly correlated to 'AGE' by Spearman correlation test
| SpearmanCorr | corrP | Q | |
|---|---|---|---|
| TMEM20 | -0.4691 | 5.241e-12 | 9.98e-08 |
| ANGPTL5 | -0.4301 | 3.881e-10 | 7.39e-06 |
| KIAA1377 | -0.4301 | 3.881e-10 | 7.39e-06 |
| JAKMIP1 | -0.4275 | 5.054e-10 | 9.62e-06 |
| AASS | -0.4139 | 1.989e-09 | 3.79e-05 |
| TBC1D12 | -0.3924 | 1.521e-08 | 0.00029 |
| CD96 | 0.3869 | 2.5e-08 | 0.000476 |
| CAMK2D | -0.3812 | 4.157e-08 | 0.000791 |
| CBLN3 | -0.3809 | 4.265e-08 | 0.000812 |
| KHNYN | -0.3809 | 4.265e-08 | 0.000812 |
Table S4. Basic characteristics of clinical feature: 'GENDER'
| GENDER | Labels | N |
| FEMALE | 89 | |
| MALE | 105 | |
| Significant markers | N = 15 | |
| Higher in MALE | 15 | |
| Higher in FEMALE | 0 |
Table S5. Get Full Table List of top 10 genes differentially expressed by 'GENDER'. 0 significant gene(s) located in sex chromosomes is(are) filtered out.
| W(pos if higher in 'MALE') | wilcoxontestP | Q | AUC | |
|---|---|---|---|---|
| DKFZP434L187 | 8773 | 6.895e-26 | 1.31e-21 | 0.9388 |
| AP2B1 | 935 | 8.831e-22 | 1.68e-17 | 0.8999 |
| FAM35A | 968 | 1.999e-21 | 3.81e-17 | 0.8964 |
| GLUD1 | 968 | 1.999e-21 | 3.81e-17 | 0.8964 |
| CROCC | 1069 | 2.333e-20 | 4.44e-16 | 0.8856 |
| KIF4B | 1238 | 1.227e-18 | 2.34e-14 | 0.8675 |
| ATP5J | 6871 | 1.696e-08 | 0.000323 | 0.7353 |
| GABPA__1 | 6871 | 1.696e-08 | 0.000323 | 0.7353 |
| LOC389791__1 | 6643 | 4.296e-07 | 0.00818 | 0.7109 |
| PTGES2__1 | 6643 | 4.296e-07 | 0.00818 | 0.7109 |
Table S6. Basic characteristics of clinical feature: 'RACE'
| RACE | Labels | N |
| ASIAN | 2 | |
| BLACK OR AFRICAN AMERICAN | 13 | |
| WHITE | 177 | |
| Significant markers | N = 4 |
-
Expresson data file = LAML-TB.meth.by_min_clin_corr.data.txt
-
Clinical data file = LAML-TB.merged_data.txt
-
Number of patients = 194
-
Number of genes = 19042
-
Number of clinical features = 4
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.